Updated Jul 16, 2026
CASCELLA ROBERT has filed 5 SEC Form 4 filings across 4 companies in the last 90 days.

Robert Cascella is a corporate executive known for his role as a director at several companies, including Neuronetics, Inc. and Mirion Technologies, Inc. He has a background in the medical technology sector, particularly in companies focused on improving patient care.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-02 | CLS | CELESTICA INC | F — Tax withholding / forfeiture | 5 | $343.25 | $2K |
| 2026-07-02 | CLS | CELESTICA INC | M — Option exercise | 84 | $0.00 | |
| 2026-07-01 | KRMD | KORU Medical Systems, Inc. | A — Grant or award | 3.6K | $4.20 | $15K |
| 2026-05-29 | STIM | Neuronetics, Inc. | A — Grant or award | 36.2K | $0.00 | |
| 2026-05-14 | MIR | Mirion Technologies, Inc. | A — Grant or award | 7.4K | $0.00 | |
| 2026-04-02 | CLS | CELESTICA INC | F — Tax withholding / forfeiture | 9 | $257.27 | $2K |
| 2026-04-02 | CLS | CELESTICA INC | M — Option exercise | 156 | $0.00 | |
| 2026-04-01 | KRMD | KORU Medical Systems, Inc. | A — Grant or award | 3.5K | $4.32 | $15K |
| 2025-10-22 | STIM | Neuronetics, Inc. | A — Grant or award | 10.5K | $0.00 | |
| 2025-10-02 | KRMD | KORU Medical Systems, Inc. | A — Grant or award | 3.9K | $3.83 | $15K |
| 2025-07-02 | KRMD | KORU Medical Systems, Inc. | A — Grant or award | 4.2K | $3.58 | $15K |
| 2025-05-22 | STIM | Neuronetics, Inc. | A — Grant or award | 36.2K | — | |
| 2025-05-15 | MIR | Mirion Technologies, Inc. | A — Grant or award | 8.0K | $0.00 | |
| 2025-04-02 | KRMD | KORU Medical Systems, Inc. | A — Grant or award | 5.9K | $2.56 | $15K |
| 2024-10-01 | KRMD | KORU Medical Systems, Inc. | A — Grant or award | 5.5K | $2.75 | $15K |
Robert Cascella is a corporate executive known for his role as a director at several companies, including Neuronetics, Inc. and Mirion Technologies, Inc. He has a background in the medical technology sector, particularly in companies focused on improving patient care.…
5 primary Form 4 filings in the last 90 days, covering 4 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live CASCELLA ROBERT profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.